Sugar-Sweetened Placebo Tablet for Diabetes Clinical Trial from China
These placebo tablets, formulated with over 10% sugar by dry weight, are used in blinded clinical trials for diabetes medications to mimic active treatments without therapeutic ingredients. They are put up in measured doses as per Chapter 30 note 4(e) and classified under 3006.93.20.00 due to their high sugar content and trial-specific packaging.
Duty Rate — China → United States
107.5%
Rate breakdown
9903.04.6089.6%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.88.157.5%Except as provided in headings 9903.88.39, 9903.88.42, 9903.88.44, 9903.88.47, 9903.88.49, 9903.88.51, 9903.88.53, 9903.88.55, 9903.88.57, 9903.88.65, 9903.88.66, 9903.88.67, 9903.88.68, or 9903.88.69, articles the product of China, as provided for in U.S. note 20(r) to this subchapter and as provided for in the subheadings enumerated in U.S. note 20(s)
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Obtain FDA approval for clinical trial materials and include IND documentation to prove 'recognized clinical trial' status
• Conduct lab analysis to confirm sugar content exceeds 10% by dry weight to avoid reclassification to lower-sugar subheadings
• Declare as placebos explicitly on entry to prevent confusion with actual medicaments under 3004